Sumatriptan: Phase II data

Data from an open-label Phase II trial showed that 51 of 52 patients were successfully able to use the Sumavel DosePro needle-free delivery system on their first attempt when treating a migraine headache. Additionally, 43 of 45 patients successfully used the system for a second time and 28 of 28 patients who used the needle-free system for a third time were successful. Data were published in Headache. ...